| For: | Lee T, Teng TZJ, Shelat VG. Carbohydrate antigen 19-9 — tumor marker: Past, present, and future. World J Gastrointest Surg 2020; 12(12): 468-490 [PMID: 33437400 DOI: 10.4240/wjgs.v12.i12.468] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v12/i12/468.htm |
| Number | Citing Articles |
| 1 |
Toshiro Masuda, Toru Beppu, Tatsunori Miyata, Hirohisa Okabe, Katsunori Imai, Katsunori Sakamoto, Yuji Miyamoto, Hiromitsu Hayashi. Prognostic Role of CA19-9 in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Cancers 2026; 18(10) doi: 10.3390/cancers18101624
|
| 2 |
Alan H.B. Wu, Chui Mei Ong, Melissa Alamillo, Zakary Clark, Christin Wong, Giman Jung. Association of apolipoprotein A2 isoform index with demographic, behavioral, and clinical risk factors for pancreatic ductal adenocarcinoma in a single-center observational study: considerations for development of a pancreatic cancer screening algorithm?. Cancer Treatment and Research Communications 2026; 48 doi: 10.1016/j.ctarc.2026.101328
|
| 3 |
Patrícia Sousa, Laurentina Silva, José S Câmara, Paula Guedes de Pinho, Rosa Perestrelo. Integrating OMICS-based platforms and analytical tools for diagnosis and management of pancreatic cancer: a review. Molecular Omics 2024; 21(2) doi: 10.1039/D4MO00187G
|
| 4 |
Ling Zhang, Ying Zhan, Bing Zhang, Zhihuan Zhao, Jianying Lin, Jing Li, Yan Cheng. Cu-Trp nanoparticle mimetic enzyme-based colorimetric immunoassay for CA19-9 detection. Analytical Methods 2026; 18(35) doi: 10.1039/D6AY01077F
|
| 5 |
Solonas Symeou, Evangelos Lolis, Georgios Glantzounis. Diagnosis and Surgical Management for Advanced Pancreatic Cancer Requiring Vascular Resection. Diagnostics 2025; 16(1) doi: 10.3390/diagnostics16010102
|
| 6 |
Hiroki Morikawa, Takaaki Oba, Ayaka Kitazawa, Ryoko Iji, Nami Kiyosawa, Masatsugu Amitani, Tadafumi Shimizu, Toshiharu Kanai, Takeshi Uehara, Ken-ichi Ito. CA19-9 producing locally advanced papillary thyroid carcinoma: a case report. Surgical Case Reports 2024; 10(1) doi: 10.1186/s40792-024-01887-w
|
| 7 |
Abd AlRahman Mohammad Foda, Tarek Atia, Hader I. Sakr, Khaled Abd Elaziz Ahmed Elnaghi, Wagih M. Abdelhay, Eman T. Enan. Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression. Journal of Evidence-Based Integrative Medicine 2023; 28 doi: 10.1177/2515690X231198315
|
| 8 |
Bhawana Yadav, Shiva Prasad Kollur, Amena Ali, Payas Arora, Aanika Gupta, P. Saranraj, Vijay Jagdish Upadhye, Pallavi Singh. Peptides as integrative modulators for clinical prognosis and targeted therapy in pancreatic cancer. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-05130-w
|
| 9 |
Amir Mahdi Nili, Kamal Mohammadian, Fatemeh Namazi Nanehkaran, Faranak Jamshidian, Arash Moradi, Shahla Mohammad Ganji. Non-invasive colorectal cancer biomarkers: HAND2 and GPM6A methylation in circulating tumour DNA. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03898-5
|
| 10 |
Han Taek Jeong, Jimin Han. Realistic Approach to Elevated Carbohydrate Antigen 19-9. Journal of Digestive Cancer Research 2024; 12(3) doi: 10.52927/jdcr.2024.12.3.171
|
| 11 |
Siddhi Awate, Dhanvi Sheth, Meena Chintamaneni, Ginpreet Kaur. Liquid biopsy in Cancer Management. 2026; doi: 10.1016/B978-0-443-27496-1.00017-8
|
| 12 |
Rowyda M. Salman, Abdullah F. Radwan, Olfat G. Shaker, Ahmed A. El-Husseiny. LncRNA MIR22HG and miR-10a-5p: Pioneering serum biomarkers for pancreatic cancer diagnosis and progression assessment. Non-coding RNA Research 2026; 20 doi: 10.1016/j.ncrna.2026.04.004
|
| 13 |
Zesheng Wang, Weiling Lu, Zhenjun Guo, Haoran Liu, Zhiwei Yin, Shihui Ma, Zhiyu Wang, Ziyue Huang, Xiaoke Sun, Yi Xu, Judy Wai Ping Yam. Recent advances in machine learning-enhanced extracellular vesicle omics for oncology. Journal of Nanobiotechnology 2026; 24(1) doi: 10.1186/s12951-026-04342-0
|
| 14 |
Alexandra-Simona Zamfir, Mihai Lucian Zabara, Raluca Ioana Arcana, Tudor Andrei Cernomaz, Andreea Zabara-Antal, Marius Traian Dragoș Marcu, Antigona Trofor, Carmen Lăcrămioara Zamfir, Radu Crișan-Dabija. Exploring the Role of Biomarkers Associated with Alveolar Damage and Dysfunction in Idiopathic Pulmonary Fibrosis—A Systematic Review. Journal of Personalized Medicine 2023; 13(11) doi: 10.3390/jpm13111607
|
| 15 |
Haiyu Wang, Yumin Ding, Shujing Zhao, Kaixu Li, Dehong Li. Establishment and validation of a nomogram model for early diagnosis of gastric cancer: a large-scale cohort study. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1463480
|
| 16 |
Keren Shen, Weixing Mo, Xiaojie Wang, Dan Shi, Wei Qian, Jihong Sun, Risheng Yu. A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features. European Radiology 2023; 33(12) doi: 10.1007/s00330-023-09873-w
|
| 17 |
·阿曼交尔 热哈提. Association of CA19-9 with Prognosis of Non-Small Cell Lung Cancer. Advances in Clinical Medicine 2024; 14(01) doi: 10.12677/ACM.2024.141081
|
| 18 |
Afshin Derakhshani, Roberta Di Fonte, Letizia Porcelli, Fatemeh Nejadi Orang, Mahdi Abdoli Shadbad, Adib Miraki Feriz, Hossein Safarpour, Antoine Dufour, Behzad Baradaran, Angela Calabrese, Mario Testini, Riccardo Memeo, Giovanna Di Meo, Leonardo Vincenti, Sonali Bhardwaj, Vito Racanelli, Nicola Silvestris, Oronzo Brunetti, Amalia Azzariti. Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma. Clinical Immunology 2026; 284 doi: 10.1016/j.clim.2026.110665
|
| 19 |
Nina Schraps, Anne Menz, Florian Viehweger, Seyma Büyücek, David Dum, Ria Schlichter, Andrea Hinsch, Christoph Fraune, Christian Bernreuther, Martina Kluth, Claudia Hube‐Magg, Katharina Möller, Viktor Reiswich, Andreas M. Luebke, Patrick Lebok, Sören Weidemann, Guido Sauter, Maximilian Lennartz, Frank Jacobsen, Till S. Clauditz, Andreas H. Marx, Ronald Simon, Stefan Steurer, Baris Mercanoglu, Nathaniel Melling, Thilo Hackert, Eike Burandt, Natalia Gorbokon, Sarah Minner, Till Krech, Florian Lutz, Morton Freytag. Pattern and Clinical Significance of CA19‐9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors. Cancer Medicine 2026; 15(3) doi: 10.1002/cam4.71710
|
| 20 |
Parinya Ruenwilai, Pattraporn Tajarernmuang, Siriporn C. Chattipakorn, Nipon Chattipakorn, Krekwit Shinlapawittayatorn. Circulating Biomarkers for Predicting Disease Progression in Idiopathic Pulmonary Fibrosis: Insights into Precision Medicine. Lung 2026; 204(1) doi: 10.1007/s00408-026-00887-x
|
| 21 |
Fushu Luo, Xiaoshun Sun, Changwu Wu, Jun Tan, Yimin Pan. Systematic Pan-Cancer Characterization of ST3GAL4 Reveals Its Prognostic and Immunologic Associations. Biomedicines 2026; 14(4) doi: 10.3390/biomedicines14040766
|
| 22 |
Sonia Perales, Carolina Torres, Cristina Jimenez-Luna, Jose Prados, Joaquina Martinez-Galan, Jose Manuel Sanchez-Manas, Octavio Caba. Liquid biopsy approach to pancreatic cancer. World Journal of Gastrointestinal Oncology 2021; 13(10): 1263-1287 doi: 10.4251/wjgo.v13.i10.1263
|
| 23 |
Yuqing Geng, Shixia Gong, Qing Xue, Jianliang You, Min Cao, Bin Xu, Yiren Lin, Zheng Sun, Chunhui Jin. LncRNA LINC01579/miR-579-3p axis promotes gastric cancer progression via NOTCH1 pathway. World Journal of Surgical Oncology 2026; 24(1) doi: 10.1186/s12957-026-04339-x
|
| 24 |
Jia Li, Xiaoying Lou, Zongdan Wang, Mengdi Wu, Jing Zhang, Huishuang Gao, Meng Li, Bing Wu, Dongmei Ma, Kuo Zhang, Wei Cui. Improving tumor marker comparability: A case series on harmonizing carbohydrate antigen 19‐9 and carbohydrate antigen 15‐3 measurements across diverse measurement systems. VIEW 2026; doi: 10.1002/viw2.70207
|
| 25 |
Chi-Huan Wu, Kai-Feng Sung, Tsung-Hsing Chen, Wei-Pin Lin, Cheng-Yu Lin, Wei-Ting Chen, Yi-Chung Hsieh, Cheng-Jen Chen, Chung-Wei Su, Jennifer Tai, Ming-Ling Chang. The CA19-9/IgG4 ratio distinguishes between cholangiocarcinoma and IgG4-related cholangitis among patients with high IgG4 levels. Asian Journal of Surgery 2026; doi: 10.1016/j.asjsur.2026.03.226
|
| 26 |
Xiwen Yang, Jiang Zhu. The VITAL prognostic model for cHCC-CCA after surgery: Integrating viral, inflammatory, tumor biology, and anatomic lesion. Surgical Oncology 2026; 69 doi: 10.1016/j.suronc.2026.102577
|
| 27 |
Angelo Bruni, Luigi Tuccillo, Giuseppe Dell’Anna, Francesco Vito Mandarino, Andrea Lisotti, Marcello Maida, Claudio Ricci, Lorenzo Fuccio, Leonardo Henry Eusebi, Giovanni Marasco, Giovanni Barbara. Endoscopic Ultrasound-Guided Pancreatic Cystic Fluid Biochemical and Genetic Analysis for the Differentiation Between Mucinous and Non-Mucinous Pancreatic Cystic Lesions. Journal of Clinical Medicine 2025; 14(11) doi: 10.3390/jcm14113825
|
| 28 |
Dayse Marcielle de Souza Lopes, Clarissa Fernandes Gomes, Cristina Paixão Durães, Larissa Lopes Fonseca, Sarah Patrícia Souza Costa, André Luiz Sena Guimarães, Sônia Ribeiro Arrudas, Guilherme Araújo Lacerda, M. G. Finn, Sílvio Fernando Guimarães de Carvalho, Ana Paula Venuto Moura, Alexandre Ferreira Marques. Sociodemographic determinants and assessment of anti-α-Gal IgG titers in head and neck cancer patients. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1686122
|
| 29 |
Safia Samir, Mohamed El-Ashry, Waleed Soliman, Marwa Hassan. Urinary biomarkers analysis as a diagnostic tool for early detection of pancreatic adenocarcinoma: Molecular quantification approach. Computational Biology and Chemistry 2024; 112 doi: 10.1016/j.compbiolchem.2024.108171
|
| 30 |
Zaki H Hakami. Biomarker discovery and validation for gastrointestinal tumors: A comprehensive review of colorectal, gastric, and liver cancers. Pathology - Research and Practice 2024; 255 doi: 10.1016/j.prp.2024.155216
|
| 31 |
Bindiya Chauhan, Bhuvnesh Kumar Singh, Tuhin James Paul, Neelanchal Trivedi. The Potential of Cancer Biomarkers. 2025; doi: 10.1016/B978-0-443-29279-8.00007-7
|
| 32 |
Nadine Rosenglick, Géraud Valentin, Kiran Marineni, Euclydes P. Neto, Peter R. Andreana. Conjugate Vaccines Targeting Tumor-Associated Carbohydrate Antigens. Vaccines 2026; 14(4) doi: 10.3390/vaccines14040287
|
| 33 |
Thomas Zheng Jie Teng, Branden Qi Yu Chua, Vishal G Shelat. Carcinosarcoma of gallbladder: A world review. World Journal of Clinical Oncology 2021; 12(12): 1244-1263 doi: 10.5306/wjco.v12.i12.1244
|
| 34 |
Ryan J Kramer, Chanjuan Shi, Dimitrios Moris, Peter J Allen. Benign Etiology for High-Risk Intraductal Papillary Mucinous Neoplasm: A Case Report and Literature Review. Cureus 2024; doi: 10.7759/cureus.62054
|
| 35 |
Vaishnavi Kuppala, Hasini Chintapudi, Gopalaiah Kovuru, Ganji Purnachandra Nagaraju, Bassel F. El-Rayes. Autophagy in cancer-associated fibroblasts: its role in gastrointestinal cancers. Molecular Cancer 2026; 25(1) doi: 10.1186/s12943-026-02626-5
|
| 36 |
Epigenetic Regulation of Cancer - Part B. International Review of Cell and Molecular Biology 2024; 383 doi: 10.1016/bs.ircmb.2023.10.002
|
| 37 |
Han Wang, Miao-Xia He, Wen-Ming Cong, Hui Dong. Immunohistochemistry in intrahepatic cholangiocarcinoma: histological subtyping and drug selection. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1653534
|
| 38 |
Ying Chen, Bo Liu, Xiaoyu Zhu. Adolescent Epstein–Barr virus–associated cholestatic jaundice with porta hepatis/pancreatic head lymphadenopathy and transient CA 19-9 elevation: a case report. Frontiers in Pediatrics 2026; 14 doi: 10.3389/fped.2026.1760882
|
| 39 |
Jorge Lindo, João Luís Fernandes, José Carlos Cardoso, Maria Manuel Xavier. Cutaneous Metastasis as the Initial Presentation of Pancreatic Adenocarcinoma. Acta Médica Portuguesa 2026; 39(6-7) doi: 10.20344/amp.24745
|
| 40 |
Sebastian Blaj, David Dora, Zoltan Lohinai, Zoltan Herold, Attila Marcell Szasz, Jonas Herzberg, Roland Kodacsi, Saher Baransi, Hans Jürgen Schlitt, Matthias Hornung, Jens M. Werner, Przemyslaw Slowik, Miklos Acs, Pompiliu Piso. Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers. Cancers 2023; 15(4) doi: 10.3390/cancers15041326
|
| 41 |
Ravi Kumar Sharma, Alpa Singh, Gaurav Sharma, Saurabh Dawra, Surinder Singh Rana. Strategy for early diagnosis of pancreatic cancer. Frontiers in Gastroenterology 2026; 5 doi: 10.3389/fgstr.2026.1731223
|
| 42 |
Longyu Liu, Zhiyao Fan, Hanxiang Zhan. Biomarkers in cystic lesions of the pancreas: Controversies and advances. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2025; 1880(5) doi: 10.1016/j.bbcan.2025.189392
|
| 43 |
Federica Vitale, Lorenzo Zileri Dal Verme, Mattia Paratore, Marcantonio Negri, Enrico Celestino Nista, Maria Elena Ainora, Giorgio Esposto, Irene Mignini, Raffaele Borriello, Linda Galasso, Sergio Alfieri, Antonio Gasbarrini, Maria Assunta Zocco, Alberto Nicoletti. The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer. Biomedicines 2024; 12(12) doi: 10.3390/biomedicines12122840
|
| 44 |
Daria Kwaśniewska, Marta M. Fudalej, Anna Badowska-Kozakiewicz, Andrzej Deptała. Evaluation of novel prognostic inflammatory markers in pancreatic cancer: a retrospective analysis of a high-volume center. Archives of Medical Science 2026; doi: 10.5114/aoms/218489
|
| 45 |
Matthew R Kudelka, Wei Gu, Yasuyuki Matsumoto, Tongzhong Ju, Richard H Barnes II, Robert J Kardish, Jamie Heimburg-Molinaro, Sylvain Lehoux, Junwei Zeng, Cynthia Cohen, Brian S Robinson, Kinjal S Shah, Elliot L Chaikof, Sean R Stowell, Richard D Cummings. Targeting altered glycosylation in secreted tumor glycoproteins for broad cancer detection. Glycobiology 2023; 33(7) doi: 10.1093/glycob/cwad035
|
| 46 |
Kenichiro Okumura, Kazuto Kozaka, Azusa Kitao, Norihide Yoneda, Takahiro Ogi, Hiroko Ikeda, Toshifumi Gabata, Satoshi Kobayashi. Imaged periductal infiltration: Diagnostic and prognostic role in intrahepatic mass-forming cholangiocarcinoma. European Journal of Radiology Open 2024; 12 doi: 10.1016/j.ejro.2024.100554
|
| 47 |
Marlies Maly, Lieve Vanwalleghem, Anja Van Den Eeckhaut, Vincent De Wilde. Cancer of unknown primary and BRAF V600E meeting the BEACON combination: A case report. Molecular and Clinical Oncology 2024; 21(6) doi: 10.3892/mco.2024.2786
|
| 48 |
Nooshin Goudarzi, Kimia Taebi, Masood Alaei, Mahdiyar Abdollahi, Farshad Foroughi, Sanaz Keshavarz Shahbaz. CA19-9 and CEA carbon nanotube-based biosensors: a key for gastrointestinal cancers diagnosis. Pure and Applied Chemistry 2025; doi: 10.1515/pac-2025-0494
|
| 49 |
Manish S. Bhandare, Gurudutt P. Varty, Ravi Chandra Reddy Obili, Amit Chopde, Akash Pawar, Krishnaveni Krishnakumar, Subhash Yadav, Vikas Ostwal, Anant Ramaswamy, Prabhat Bhargava, Vikram Chaudhari, Shailesh V. Shrikhande. CA 19-9 Surveillance Detects Recurrences Early and Contributes to Improvement in Survival in Resected Ampullary Cancers. Annals of Surgery 2026; 283(2) doi: 10.1097/SLA.0000000000006419
|
| 50 |
Austin D. Silva, Jihye Hwang, Michael P. Marciel, Susan L. Bellis. The pro-inflammatory cytokines IL-1β and IL-6 promote upregulation of the ST6GAL1 sialyltransferase in pancreatic cancer cells. Journal of Biological Chemistry 2024; 300(10) doi: 10.1016/j.jbc.2024.107752
|
| 51 |
P. M. Sokolov, P. S. Samokhvalov, D. A. Baranova, A. V. Sukhanova. Principles and approaches in the development of fluorescent hydrogels for cancer diagnosis. Russian Journal of Biotherapy 2023; 22(4) doi: 10.17650/1726-9784-2023-22-4-17-27
|
| 52 |
Muhammad Ghallab, Hazem Abosheaishaa, Ishank Gupta, Salma Abdelmoteleb, Roger Stern. A Case of Choledocholithiasis and Obstructive Jaundice With a Very High Serum Carbohydrate Antigen 19-9 (CA 19-9) Level: A Case Report and Review of Literature. Cureus 2022; doi: 10.7759/cureus.32447
|
| 53 |
Kendelle J. Murphy, Cecilia R. Chambers, David Herrmann, Paul Timpson, Brooke A. Pereira. Dynamic Stromal Alterations Influence Tumor-Stroma Crosstalk to Promote Pancreatic Cancer and Treatment Resistance. Cancers 2021; 13(14) doi: 10.3390/cancers13143481
|
| 54 |
V. L. Ostanko, T. P. Kalacheva, K. A. Kulumaeva, N. A. Li, E. V. Beloborodova, I. L. Purlik, E. V. Kalyuzhina, N. G. Brazovskaya, V. V. Kalyuzhin. Markers of gastrointestinal diseases. Bulletin of Siberian Medicine 2025; 23(4) doi: 10.20538/1682-0363-2024-4-177-186
|
| 55 |
Jongkonnee Wongpiyabovorn, Nasornthan Yutthakasaemsan, Sunida Vandelaer. Comparative Analytical Performance and Clinical Agreement of Chemiluminescence Microparticle Immunoassay and Electrochemiluminescence Immunoassay for CA19-9: A Diagnostic Accuracy Study. Diagnostics 2026; 16(16) doi: 10.3390/diagnostics16162638
|
| 56 |
Fabienne Weber, Aina Valenti, Jiří Ledvinka, Oren Moscovitz, Peter H. Seeberger. Untersuchung von Anti‐Glykan‐Antikörpern und Erforschung ihres medizinischen Potenzials mithilfe synthetischer Glykane. Angewandte Chemie 2026; 138(39) doi: 10.1002/ange.7795967
|
| 57 |
Sara Ansari, Parvaneh Nikpour. Identification of Cancer/Testis Antigens Related to Gastric Cancer Prognosis Based on Co-Expression Network and Integrated Transcriptome Analyses. Advanced Biomedical Research 2023; 12(1) doi: 10.4103/abr.abr_400_21
|
| 58 |
Reem A. Qannita, Ruba A. Zenati, Ahmad Y. Abuhelwa, Mohammad A.Y. Alqudah, Shereen M. Aleidi, Waseem El-Huneidi, Eman Abu-Gharbieh, Zainab M. AlShareef, Karem H. Alzoubi, Yasser Bustanji, Mohammad H. Semreen. Emerging biomarkers for early detection of colorectal cancer. Clinica Chimica Acta 2026; 589 doi: 10.1016/j.cca.2026.121013
|
| 59 |
Daniyal Raza, Sahib Singh, Stefano Francesco Crinò, Ivo Boskoski, Cristiano Spada, Lorenzo Fuccio, Jayanta Samanta, Jahnvi Dhar, Marco Spadaccini, Paraskevas Gkolfakis, Marcello Fabio Maida, Jorge Machicado, Marcello Spampinato, Antonio Facciorusso. Diagnostic Approach to Biliary Strictures. Diagnostics 2025; 15(3) doi: 10.3390/diagnostics15030325
|
| 60 |
Kim-Lea Reese, Klaus Pantel, Daniel J. Smit. Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer – a comprehensive review. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-024-03166-w
|
| 61 |
Mohamed Saber Mostafa, Dina Hamour, George Abdelfady Nashed Aiad, Hany Armia Balamoun, Mohamed Hamdy Khattab, Mohamed Nasr Shazly, Mohamed Elshawadfy Nageeb, Abdelkarem Ahmed Abdelkarem Mohamed. Laparoscopic versus open pancreatoduodenectomy: a pilot randomized trial in a developing African country. Surgical Endoscopy 2026; 40(2) doi: 10.1007/s00464-025-12377-x
|
| 62 |
Yong-Mei Huang, Yu-Chen Wei, Xing-Qing Qin, Meng-Na Lan, Jin-Yuan Liao. Time-dependent diffusion-weighted MRI discriminates hepatocellular carcinoma from intrahepatic cholangiocarcinoma: A prospective animal model study. Magnetic Resonance Imaging 2026; 127 doi: 10.1016/j.mri.2025.110601
|
| 63 |
Wei-Yi Zhao, Jin-Wei Zhao. Pancreatic cancer immunotherapy biomarkers: from traditional markers to multimodal integration and dynamic monitoring. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1686658
|
| 64 |
Kamil Safiejko, Marcin Juchimiuk, Jacek Pierko, Maciej Maslyk, Mateusz Mucha, Mariusz Koda, Luiza Konczuga-Koda, Sebastian Radej, Adem Akcakaya, Lukasz Szarpak. Liquid Biopsy in Gastrointestinal Cancers: Circulating Tumor DNA for Molecular Residual Disease Assessment and Early Treatment Monitoring. Cancers 2026; 18(6) doi: 10.3390/cancers18061014
|
| 65 |
Jaume Trapé, Esther Fernández-Galán, Josep Maria Auge, Marina Carbonell-Prat, Xavier Filella, Sílvia Miró-Cañís, Carolina González-Fernández. Factors influencing blood tumor marker concentrations in the absence of neoplasia. Tumor Biology 2024; 46(s1) doi: 10.3233/TUB-220023
|
| 66 |
Giampaolo Perri, Santhi Swaroop Vege, Giovanni Marchegiani. Monitoring Ca19‐9 during pancreatic cyst surveillance: Better safe than sorry?. United European Gastroenterology Journal 2023; 11(7) doi: 10.1002/ueg2.12449
|
| 67 |
Luigi Brancato, Damar Osok, Laurent Van den Bossche, Eric Van Cutsem, Susan Bates, Johan Van den Bossche, Johannes Bogers. CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma. Cancers 2025; 17(24) doi: 10.3390/cancers17243902
|
| 68 |
Bryson W. Katona, Christine Worthington, Daniel Clay, Hannah Cincotta, Nuzhat A. Ahmad, Gregory G. Ginsberg, Michael L. Kochman, Randall E. Brand. Outcomes of the IMMray PanCan-d Test in High-Risk Individuals Undergoing Pancreatic Surveillance: Pragmatic Data and Lessons Learned. JCO Precision Oncology 2023; (7) doi: 10.1200/PO.23.00445
|
| 69 |
Luis Secanella, Juli Busquets, Núria Peláez, María Sorribas, Berta Laquente, Sandra Ruiz-Osuna, Juan Fabregat. The involvement of the hepatic artery is a risk factor for unresectability after neoadjuvant treatment in borderline pancreatic adenocarcinoma. Surgical Oncology 2024; 52 doi: 10.1016/j.suronc.2023.102027
|
| 70 |
Antonio Facciorusso, Stefano Francesco Crinò, Paraskevas Gkolfakis, Marco Spadaccini, Marianna Arvanitakis, Torsten Beyna, Michiel Bronswijk, Jahnvi Dhar, Mark Ellrichmann, Rodica Gincul, Istvan Hritz, Leena Kylänpää, Belen Martinez-Moreno, Martina Pezzullo, Mihai Rimbaş, Jayanta Samanta, Roy L.J. van Wanrooij, George Webster, Konstantinos Triantafyllou. Diagnostic work-up of bile duct strictures: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2025; 57(02) doi: 10.1055/a-2481-7048
|
| 71 |
Hiroaki Shibahara, Atsufumi Takeuchi, Yasuko Fujii, Yoriko Yamashita. Sister Mary Joseph’s Nodule Presenting with an Ulcerated Umbilicus as an External Diagnostic Clue Revealing a Deeply Situated Pancreatic Tail Cancer. Case Reports in Oncology 2026; 19(1) doi: 10.1159/000550841
|
| 72 |
Jagannath Mondal, Jeong Man An, Sachin S. Surwase, Kushal Chakraborty, Sabuj Chandra Sutradhar, Joon Hwang, Jaewook Lee, Yong-Kyu Lee. Carbon Nanotube and Its Derived Nanomaterials Based High Performance Biosensing Platform. Biosensors 2022; 12(9) doi: 10.3390/bios12090731
|
| 73 |
Di Wang, Katarina Madunić, Oleg A. Mayboroda, Guinevere S.M. Lageveen-Kammeijer, Manfred Wuhrer. (Sialyl)Lewis Antigen Expression on Glycosphingolipids, N-, and O-Glycans in Colorectal Cancer Cell Lines is Linked to a Colon-Like Differentiation Program. Molecular & Cellular Proteomics 2024; 23(6) doi: 10.1016/j.mcpro.2024.100776
|
| 74 |
Huifen Shen, Fei Zuo. Prognostic role of systemic inflammation response index (SIRI) in patients with pancreatic cancer: a meta-analysis. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1465279
|
| 75 |
Luca Digiacomo, Damiano Caputo, Roberto Cammarata, Vincenzo La Vaccara, Roberto Coppola, Erica Quagliarini, Manuela Iacobini, Serena Renzi, Francesca Giulimondi, Daniela Pozzi, Giulio Caracciolo, Heinz Amenitsch. Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. Nanoscale 2025; 17(12) doi: 10.1039/D4NR02435D
|
| 76 |
Adriel Yan Sheng Tan, Faliang Cheng, Min Zhang, Michelle T.T. Tan, Sivakumar Manickam, Kasturi Muthoosamy. Graphitic carbon nitride/1-pyrenebutyric acid N-hydroxysuccinimide/polythiophene nanocomposite photoelectrochemical biosensor for CA 19-9 detection. Talanta 2025; 293 doi: 10.1016/j.talanta.2025.128065
|
| 77 |
Jacek Baj, Łukasz Bryliński, Filip Woliński, Michał Granat, Katarzyna Kostelecka, Piotr Duda, Jolanta Flieger, Grzegorz Teresiński, Grzegorz Buszewicz, Marzena Furtak-Niczyporuk, Piero Portincasa. Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know. Cancers 2022; 14(6) doi: 10.3390/cancers14061493
|
| 78 |
Rashid Mir, Ulfat Jan, Jameel Barnawi, Naseh A. Algehainy, Mohammed M. Jalal, Malik A. Altayar, Reema M. Almotairi, Tarig Ms Alnour, Syed Khalid Mustafa, Abdulaziz S. Al-Otaibi, Adel D. Althaqafy, Elham M. Alhathli, Salma Alrdahe, Mohammad Muzaffar Mir, Nada Zaki Sageer, Abdullatif Taha Babakr, Afaq Ahmad Khan. Extracellular derived-exosomal micrornas in pancreatic cancer: investigating their diagnostic importance and potential targets for the prevention and treatment in pancreatic cancer. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1669213
|
| 79 |
Beatriz A. Gonzales, Alessandro L. Diniz, Silvio M. Torres, Héber Salvador de Castro Ribeiro, Igor Correia de Farias, André Luís de Godoy, Felipe J. F. Coimbra, Victor H. Fonseca de Jesus. Patterns of disease relapse and posttreatment follow‐up of patients with resected pancreatic adenocarcinoma: A single‐center analysis. Journal of Surgical Oncology 2022; 126(4) doi: 10.1002/jso.26985
|
| 80 |
Sima Kalantari, Akram Pourshams, Raheleh Roudi, Hakimeh Zali, Mojgan Bandehpour, Abolfazl Kalantari, Reza Ghanbari, Alberto D'Angelo, Bahram Kazemi, Zahra Madjd. Identification of Potential Common Molecular Factors of Pancreatic Cancer and Diabetes Mellitus using Microarray Data Analysis Combined with Bioinformatics Techniques and Experimental Validation. Biomedical and Biotechnology Research Journal (BBRJ) 2021; 5(3) doi: 10.4103/bbrj.bbrj_122_21
|
| 81 |
Luis Gonzalez Miranda, Jessica Qiu, Yubo Wu, Kirsten Greene, Kalyani Sen. Retroperitoneal Mystery: Primary Retroperitoneal Mucinous Cystic Neoplasm With Concomitant Cystic Neoplasm of the Pancreas. Case Reports in Urology 2025; 2025(1) doi: 10.1155/criu/3296313
|
| 82 |
Peter Mačinga, Jiří Zahradník, Tomáš Hucl, Radoslav Janoštiak. Bridging the intraductal papillary mucinous neoplasm risk stratification gap: A critical review of current and emerging biomarkers. World Journal of Gastrointestinal Oncology 2026; 18(8): 120019 doi: 10.4251/wjgo.120019
|
| 83 |
Brian M. Fung, James H. Tabibian. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices. Expert Review of Gastroenterology & Hepatology 2021; 15(5) doi: 10.1080/17474124.2021.1900732
|
| 84 |
Taisuke Imamura, Katsuhisa Ohgi, Yukiyasu Okamura, Teiichi Sugiura, Takaaki Ito, Yusuke Yamamoto, Ryo Ashida, Shimpei Otsuka, Shunsuke Tamura, Katsuhiko Uesaka. The clinical benefits of performing staging laparoscopy for pancreatic cancer treatment. Pancreatology 2022; 22(5) doi: 10.1016/j.pan.2022.03.017
|
| 85 |
. 2022; doi: 10.70675/719fdcd4z34b2z4802z8e35z27bfba5f3205
|
| 86 |
So Jeong Yoon, Seung Soo Hong, Kee-Taek Jang, So Kyung Yoon, Hongbeom Kim, Sang Hyun Shin, Jin Seok Heo, Chang Moo Kang, Kyung Sik Kim, Ho Kyoung Hwang, In Woong Han. Predicting lymph node metastasis using preoperative parameters in patients with T1 ampulla of vater cancer. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12311-9
|
| 87 |
Mafalda Angelica Rocco, Milda Kirvaitytė, Giulia Lencioni, Stefano Mariani, Liam A. McDonnell, Mouraya Hussein, Elisa Giovannetti. CRISPR-based diagnostics as a specificity layer for the early detection of pancreatic cancer. Cancer Letters 2026; 661 doi: 10.1016/j.canlet.2026.218851
|
| 88 |
Phyllis A. Gimotty, Jacob E. Till, Shirsa Udgata, Naomi Takenaka, Stephanie S. Yee, Michael J. LaRiviere, Mark H. O’Hara, Kim A. Reiss, Peter O'Dwyer, Bryson W. Katona, Daniel Herman, Erica L. Carpenter, Kenneth S. Zaret. THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma. Oncotarget 2021; 12(22) doi: 10.18632/oncotarget.28099
|
| 89 |
Yuanyuan Jiang, Shichao Duan, Jiaming Li, Yanli Zhao, Jinsong Yang. Chemical and chemoenzymatic syntheses of sialyl Lewisa tetrasaccharide antigen. Organic & Biomolecular Chemistry 2024; 22(28) doi: 10.1039/D4OB00809J
|
| 90 |
Madhulika L. Mahashabde, Lokesh Kumar, Jugal P. Sriram, Brugumalla V. Nitendra Saketh. The Diagnostic Pitfalls of Extremely High Tumor Biomarker Levels. Medical Journal of Dr. D.Y. Patil Vidyapeeth 2025; 18(5) doi: 10.4103/mjdrdypu.mjdrdypu_503_24
|
| 91 |
Esther N. Dekker, Jacob L. van Dam, Quisette P. Janssen, Marc G. Besselink, Annissa DeSilva, Deesje Doppenberg, Casper H.J. van Eijck, Naaz Nasar, Eileen M. O'Reilly, Alessandro Paniccia, Laura R. Prakash, Ching-Wei D. Tzeng, Eva M.M. Verkolf, Alice C. Wei, Amer H. Zureikat, Matthew H.G. Katz, Bas Groot Koerkamp, Rudy el Asmar, Dana Haviland, Crisanta Ilagan, Caitlin McIntyre, Sarah McIntyre, Thomas F. Stoop, Rutger T. Theijse. Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study. Journal of Clinical Oncology 2024; 42(12) doi: 10.1200/JCO.23.01311
|
| 92 |
Yijiao Chen, Dexiang Zhu, Miao Chen, Yuqiu Xu, Qinghai Ye, Xiaoying Wang, Pingping Xu, Qingyang Feng, Meiling Ji, Ye Wei, Jia Fan, Jianmin Xu. Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis: A Retrospective Cohort Study. Clinical Colorectal Cancer 2023; 22(4) doi: 10.1016/j.clcc.2023.08.007
|
| 93 |
Anil Aysal, Ozgul Sagol. Biomarkers in Carcinoma of Unknown Primary. 2022; doi: 10.1007/978-3-030-84432-5_8
|
| 94 |
Jin-Lei Wang, Xiang Li, Jia-Ru Fan, Jia-Ping Yan, Ze-Mao Gong, Yue Zhao, Dong-Mei Wang, Li Ma, Na Ma, Diao-Mei Guo, Lian-Sheng Ma. Integrity of the editing and publishing process is the basis for improving an academic journal’s Impact Factor. World Journal of Gastroenterology 2022; 28(43): 6168-6202 doi: 10.3748/wjg.v28.i43.6168
|
| 95 |
Olga Y. Burenina, Natalia L. Lazarevich, Inna F. Kustova, Daria A. Shavochkina, Ekaterina A. Moroz, Nikolay E. Kudashkin, Yuriy I. Patyutko, Maria P. Rubtsova, Olga A. Dontsova.
Upregulation of long noncoding RNAs
LINC00941
and
ABHD11-AS1
is associated with intrahepatic cholangiocarcinoma
. Science Progress 2025; 108(1) doi: 10.1177/00368504251330019
|
| 96 |
Hui Li, Rongqiang Liu, Haizhou Qiu, Yang Huang, Wenbin Liu, Jiaxin Li, Hong Wu, Genshu Wang, Dewei Li. Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.829407
|
| 97 |
Sangam Singh, Punet Kumar, Deepak Kumar, Arun Kumar Mishra. Innovative Therapies for Pancreatic Cancer. 2025; doi: 10.4018/979-8-3373-1469-3.ch010
|
| 98 |
Federica Colapietra, Paola Della Monica, Raffaella Di Napoli, Fábio França Vieira e Silva, Giuliana Settembre, Maria Michela Marino, Andrea Ballini, Stefania Cantore, Marina Di Domenico. Epigenetic Modifications as Novel Biomarkers for Diagnosis, Prognosis, and Therapeutic Targeting in Thyroid, Pancreas, and Lung Neuroendocrine Tumors. Journal of Clinical Medicine 2025; 14(8) doi: 10.3390/jcm14082622
|
| 99 |
Pobporn Danvirutai, Thatsanapong Pongking, Suppakrit Kongsintaweesuk, Somchai Pinlaor, Sartra Wongthanavasu, Chavis Srichan. Highly Accurate and Robust Early Stage Detection of Cholangiocarcinoma Using Near-Lossless SERS Signal Processing with Machine Learning and 2D CNN for Point-of-care Mobile Application. ACS Omega 2025; 10(11) doi: 10.1021/acsomega.4c11078
|
| 100 |
Hüseyin Kocaaslan, Fatih Sümer. The impact of preoperative CEA and CA 19-9 levels on early and late postoperative outcomes in patients undergoing laparoscopic gastrectomy for gastric adenocarcinoma. Journal of Medicine and Palliative Care 2026; 7(2) doi: 10.47582/jompac.1860634
|
| 101 |
Imteyaz Ahmad Khan, Nidhi Singh, Deepak Gunjan, Baibaswata Nayak, Nihar Ranjan Dash, Sujoy Pal, Neelam Lohani, Rajni Yadav, Surabhi Gupta, Anoop Saraya. Serum miR‐215‐5p, miR‐192‐5p and miR-378a-5p as novel diagnostic biomarkers for periampullary adenocarcinoma. Pathology - Research and Practice 2024; 260 doi: 10.1016/j.prp.2024.155417
|
| 102 |
Tsinrong Lee, Thomas Zheng Jie Teng, Vishal G Shelat. Choledochoscopy: An update. World Journal of Gastrointestinal Endoscopy 2021; 13(12): 571-592 doi: 10.4253/wjge.v13.i12.571
|
| 103 |
Christina Jane Vellan, Koh Peng Soon, Azlina Abdul Aziz, Jaime Jacqueline Jayapalan. Circadian-rhythm-based dynamics of the secretome in molecular subtypes of pancreatic ductal adenocarcinoma. Expert Review of Proteomics 2026; 23(6) doi: 10.1080/14789450.2026.2634792
|
| 104 |
Yinjiao Wang, Yu Lou, Lang Chen, Xin Yang, Aihong Cao, Peng Du. A hepatic sparganosis misdiagnosed as intrahepatic mass-forming cholangiocarcinoma: a case report and literature review. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1391256
|
| 105 |
Toshiya Nakashima, Hiroshi Ito, Koki Kikuchi. Secondary syphilis presenting with elevated CA19-9: A report of two cases. International Journal of STD & AIDS 2025; 36(9) doi: 10.1177/09564624251348680
|
| 106 |
Kei Yamane, Koshiro Morino, Takayuki Anazawa, Kazuyuki Nagai, Asahi Sato, Michio Yoshimura, Takahiro Iwai, Junichi Matsubara, Akihisa Fukuda, Hiroyoshi Isoda, Satoshi Ogiso, Yoichiro Uchida, Takashi Ito, Takamichi Ishii, Yu Hidaka, Yumiko Ibi, Etsuro Hatano. Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatment benefits. Pancreatology 2025; 25(6) doi: 10.1016/j.pan.2025.04.012
|
| 107 |
Erkan Topkan, Ugur Selek, Berrin Pehlivan, Ahmet Kucuk, Veysel Haksoyler, Nulifer Kilic Durankus, Duygu Sezen, Yasemin Bolukbasi. The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy. Journal of Inflammation Research 2021; doi: 10.2147/JIR.S329611
|
| 108 |
Weihua Zhao, Tongyan Zhang. Bartholin's gland cyst with markedly elevated CA19‑9 level: A case report. Experimental and Therapeutic Medicine 2025; 30(6) doi: 10.3892/etm.2025.12976
|
| 109 |
Eiji Narusawa, Yukiko Nakano, Seshiru Nakazawa, Kanji Hori, Yoichi Ohtaki, Natsuko Kawatani, Tomohiro Yazawa, Ryohei Yoshikawa, Kazuki Numajiri, Ryo Kuriyama, Hiroshi Kurokawa, Yoshihiro Taguchi, Seyed Zadeh, Haruka Okami, Takuya Shiraishi, Nobuhiro Nakazawa, Takamichi Igarashi, Kyoichi Kaira, Hiroshi Saeki, Ken Shirabe, Takehiko Yokobori. Lectin‑captured plasma microRNAs predict response and survival in patients with non‑small cell lung cancer treated with nivolumab. Oncology Letters 2026; 32(1) doi: 10.3892/ol.2026.15669
|
| 110 |
Fardad Ejtehadi, Saeid Hashemieh, Ali Reza Safarpour, Sara Shojaei-Zarghani, Salar Azadnik, Alireza Shamsaeefar, Nima Rahimikashkooli. Risk Factors of Incidental Cholangiocarcinoma in Primary Sclerosing Cholangitis: A Cross-Sectional Study with ROC Curve Analysis. Archives of Iranian Medicine 2026; 29(1) doi: 10.34172/aim.34922
|
| 111 |
Anna Paula de Oliveira Souza, Lucas Alves de Lima, Paula Angelica Burgos Ferreira, Rosa Fireman Dutra. Advances in Cervical Cancer Diagnostics Based on Immunosensors: Innovative Approaches and Tumor Biomarkers. Current Topics in Medicinal Chemistry 2026; 26(5) doi: 10.2174/0115680266366335250314081522
|
| 112 |
Chuanpei Cao, Fan Tang, Zhihua Zhu, Feng Wang, Jinfeng Li. Serum ferritin as a potential biomarker for distinguishing advanced-stage colorectal cancer: a retrospective cohort study. PeerJ 2026; 14 doi: 10.7717/peerj.21449
|
| 113 |
Elena I. Dyachenko, Lyudmila V. Bel’skaya. The Mechanism and Pathways of Formation and Modification of Salivary Metabolic Profile in Cancer. Current Issues in Molecular Biology 2026; 48(7) doi: 10.3390/cimb48070728
|
| 114 |
Marcel Kremser, Nathalie Weiss, Anne Kaufmann-Stoeck, Laura Vierbaum, Arthur Schmitz, Ingo Schellenberg, Stefan Holdenrieder. Longitudinal evaluation of external quality assessment results for CA 15-3, CA 19-9, and CA 125. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1401619
|
| 115 |
Guan Tan, Wen-Qiang Wang, Tong Yuan, Jun-Jie Liu, Zhen-Hui Xie, Zun-Yi Zhang, Zhi-Yong Huang. Machine learning prediction of perineural invasion in intrahepatic cholangiocarcinoma. European Journal of Surgical Oncology 2025; 51(9) doi: 10.1016/j.ejso.2025.110203
|
| 116 |
Daniel Vasile Balaban, Flavius Stefan Marin, George Manucu, Andreea Zoican, Marina Ciochina, Victor Mina, Cristina Patoni, Catalina Vladut, Sandica Bucurica, Raluca Simona Costache, Florentina Ionita-Radu, Mariana Jinga. Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer. World Journal of Clinical Oncology 2022; 13(7): 630-640 doi: 10.5306/wjco.v13.i7.630
|
| 117 |
Chanza F. Shaikh, Laura Alaimo, Zorays Moazzam, Yutaka Endo, Henrique A. Lima, Zaiba Dawood, Muhammad M. Munir, Timothy M. Pawlik. Predicting overall and recurrence‐free survival in patients with intrahepatic cholangiocarcinoma using the MEGNA score: A multi‐institutional analysis. Journal of Surgical Oncology 2023; 127(1) doi: 10.1002/jso.27098
|
| 118 |
Ayesha Anwar, Rabia Khanum, Maarij Faridi, Waseem Akram, Misbah Mahmood. Role of CA 19-9/CRP Ratio as A Predictor for Malignancy in Obstructed Jaundice Patient. Pakistan Journal of Health Sciences 2024; doi: 10.54393/pjhs.v5i12.2123
|
| 119 |
Jia Jia Wee, Charles K F Vu, Cristine Szu Lyn Ding, Vishal G Shelat. Intrapancreatic accessory spleen with an epidermoid cyst: a malignant mimicry. BMJ Case Reports 2022; 15(2) doi: 10.1136/bcr-2021-247737
|
| 120 |
Kai Siang Chan, Vishal Shelat. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases. 2022; doi: 10.1007/978-981-19-0063-1_66
|
| 121 |
Zorays Moazzam, Laura Alaimo, Yutaka Endo, Henrique A Lima, Andrea Ruzzenente, Alfredo Guglielmi, Luca Aldrighetti, Matthew Weiss, Todd W Bauer, Sorin Alexandrescu, George A Poultsides, Shishir K Maithel, Hugo P Marques, Guillaume Martel, Carlo Pulitano, Feng Shen, François Cauchy, Bas Groot Koerkamp, Itaru Endo, Jordan Cloyd, Aslam Ejaz, Timothy M Pawlik. Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma. Journal of the American College of Surgeons 2023; 236(4) doi: 10.1097/XCS.0000000000000557
|
| 122 |
Xinyu Cheng, Jianguo Xia, Qi Xu, Huawei Gui. The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer. Open Medicine 2023; 18(1) doi: 10.1515/med-2023-0805
|
| 123 |
Mikkel Koed Møller Aasted, Thapakorn Jaroentomeechai, Sally Dabelsteen, Hiren Joshi, Sean R. Stowell, Hans H. Wandall. From Glycocode
to Precision Oncology: Therapeutic
Strategies Targeting Aberrant O-GalNAc Glycosylation
in Cancer. Chemical Reviews 2026; 126(16) doi: 10.1021/acs.chemrev.5c00901
|
| 124 |
Francesca Pezzuto, Francesco Izzo, Pasquale De Luca, Elio Biffali, Luigi Buonaguro, Fabiana Tatangelo, Franco Maria Buonaguro, Maria Lina Tornesello. Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma. Cancers 2021; 13(15) doi: 10.3390/cancers13153771
|
| 125 |
Somya Rajput, Rekha Khandia, Trisha Gaur, Ananya Anant, Mohammad Amjad Kamal, Pankaj Gurjar, Sami A. Al-Hussain, Magdi E. A. Zaki. Advancements in nanobiosensors for early cancer detection, challenges, treatment, and future prospects: a comprehensive review. Discover Nano 2026; 21(1) doi: 10.1186/s11671-026-04478-w
|
| 126 |
Tetiana Glushko, James Costello, Ranjit Chima, Melissa McGettigan, Richard Kim, Daniel Jeong, Aliya Qayyum. Molecular signatures of intrahepatic cholangiocarcinoma: role in targeted therapy selection. European Journal of Radiology 2025; 187 doi: 10.1016/j.ejrad.2025.112056
|
| 127 |
Nida Ansari, Sacide S Ozgur, Damian Besada, Noor Bittar, Gabriel Melki, Kanthi Badipatla, Derick Christian, Yana Cavanagh. Carbohydrate Antigen (CA 19-9) Surge: Unraveling the Enigma of Elevated Levels in the Setting of Benign Etiologies. Cureus 2024; doi: 10.7759/cureus.57469
|
| 128 |
Kartikeya Mathur, Chhagan Lal Birda, Ankit Agarwal, Ashish Agarwal. Differential Diagnosis and Management of Pancreatic Cystic Lesions. 2026; doi: 10.1007/978-981-92-0654-4_9
|
| 129 |
Haoming Tang, Yi Xin Li, Jun Jie Lian, Hsin-Yueh Ng, Samuel Sherng Young Wang. Personalized treatment using predictive biomarkers in solid organ malignancies: A review. Tumori Journal 2024; 110(5) doi: 10.1177/03008916241261484
|
| 130 |
Emel Akbaba, Deniz Karataş, Ataman Gönel, Ezgi Soylu, Beste Kiraz, Yusur Ammar Almahdi. Investigation of a Stable Interaction of Levothyroxine with AFP Through Molecular Modelling. Cumhuriyet Science Journal 2025; 46(2) doi: 10.17776/csj.1599148
|
| 131 |
Hedyeh Rahmani, Samira Mansouri Majd, Abdollah Salimi, Foad Ghasemi. Ultrasensitive immunosensor for monitoring of CA 19-9 pancreatic cancer marker using electrolyte-gated TiS3 nanoribbons field-effect transistor. Talanta 2023; 257 doi: 10.1016/j.talanta.2023.124336
|
| 132 |
Vinay K. Pattalachinti, Ashlee Seldomridge, Abdelrahman Yousef, Mahmoud Yousef, Eleanor A. Fallon, Jacquelyn McCullough, Betul Beyza Gunes, Yun Song, Christopher P. Scally, Paul Mansfield, Michael G. White, Keith F. Fournier, Beth A. Helmink, John Paul Shen. Appendiceal Adenocarcinoma Cytoreduction Outcomes and Perioperative Serum Tumor Marker Levels. JAMA Network Open 2026; 9(5) doi: 10.1001/jamanetworkopen.2026.10569
|
| 133 |
Taskeen Ebrahim, Willem Perold, Anna-Mart Engelbrecht. A Capacitive Biosensor for the Early Detection of Pancreatic Cancer Using Carbohydrate Antigen 19-9. The 9th International Electronic Conference on Sensors and Applications 2022; doi: 10.3390/ecsa-9-13322
|
| 134 |
Shahnam Valizadeh Shahbazlou, Somayeh Vandghanooni, Bahareh Dabirmanesh, Morteza Eskandani, Sadegh Hasannia. Recent advances in surface plasmon resonance for the detection of ovarian cancer biomarkers: a thorough review. Microchimica Acta 2024; 191(11) doi: 10.1007/s00604-024-06740-3
|
| 135 |
Ruth González-Gómez, Roberto A. Pazo-Cid, Luis Sarría, Miguel Ángel Morcillo, Alberto J. Schuhmacher. Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography. Journal of Clinical Medicine 2021; 10(6) doi: 10.3390/jcm10061151
|
| 136 |
Murshidul Arefin, Md. Kawsar Bhuiyan, Anupam Debnath, Golam Mahmud Rayhan, Sabuj Kumar Patra, Nur Alam Mohim, Mohammad Saief Uddin, Salma A Tohfa, Amit Chowdhury, Shah Md. Ezaz-ul Haque. Mean Platelet Volume-to-Platelet Ratio as a Preoperative Marker for Distinguishing Pancreatic Cancer and Chronic Pancreatitis. Cureus 2026; doi: 10.7759/cureus.111354
|
| 137 |
Yizhen Zhang, Qingwei Jiang, Qiang Wang, Yunlu Feng, Dongsheng Wu, Tao Guo, Shengyu Zhang, Xi Chen, Yingyun Yang, Wen Shi, Xi Wu, Aiming Yang. Predicting Malignancy of Biliary Stricture with a Nomogram in Patients with a Non-Malignant Endoscopic Tissue Diagnosis: A Retrospective Study. Cancer Management and Research 2021; doi: 10.2147/CMAR.S333333
|
| 138 |
Ling Zhang, Yuichiro Uchida, Midori Saito, Hayato Ichikawa, Kunpei Hada, Masato Hoshi, Takeshi Takahara, Hiroyasu Ito, Koichi Suda. Clinical significance of inter-assay discrepancies in serum CA19-9 values: A comparison between CLIA and ECLIA. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2026; doi: 10.1177/00045632261491148
|
| 139 |
Francesco Muraca, Fausto Gueths Gomes, Gustavo Marçal Schmidt Garcia Moreira, Matthias Ocker. Novel Approaches in Cancer Treatment. Handbook of Cancer and Immunology 2025; 8 doi: 10.1007/978-3-032-00771-1_405
|
| 140 |
Shigemasa Takamizawa, Tatsunori Shimoi, Masayuki Yoshida, Momoko Tokura, Shu Yazaki, Chiharu Mizoguchi, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Yuki Kojima, Hitomi Sumiyoshi-Okuma, Tadaaki Nishikawa, Emi Noguchi, Kazuki Sudo, Kan Yonemori. Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09514-3
|
| 141 |
Yali Zhang, Jin Luan, Yingying Xu, Ping Tang, Ganlu Xu, Jianguang Zhu, Xiaomei Wang, Ling Hu. From static to dynamic: An AI-integrated spatiotemporal model for early cancer detection via multi-omics liquid biopsy. Genes & Diseases 2026; doi: 10.1016/j.gendis.2026.102298
|
| 142 |
Takashi Utsunomiya, Noboru Ideno, Keiichi Shigematsu, Yoshiyuki Nakanishi, Tomoyuki Araki, Takeo Yamamoto, Toshiya Abe, Yusuke Watanabe, Naoki Ikenaga, Kohei Nakata, Kenoki Ohuchida, Shinichi Aishima, Yoshinao Oda, Hideya Onishi. S100A6 expression in resected specimens predicts lymph node metastasis in small pancreatic ductal adenocarcinoma: A retrospective cohort study. Surgery 2026; 198 doi: 10.1016/j.surg.2026.110423
|
| 143 |
Joao Victor Machado Carvalho, Valérie Dutoit, Claudia Corrò, Thibaud Koessler. Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. Cells 2023; 12(3) doi: 10.3390/cells12030413
|
| 144 |
Wenfeng Xi, Wanying Liao, Tao Guo, Qingwei Jiang, Xiaoyin Bai, Xi Wu, Yunlu Feng, Shengyu Zhang, Dongsheng Wu, Qiang Wang, Aiming Yang. CA19-9/DBil: a promising indicator to distinguish between CA19-9-elevated pancreatic head-type autoimmune pancreatitis and pancreatic head cancer. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03925-9
|
| 145 |
Mark Bates, Bashir M. Mohamed, Faye Lewis, Sharon O’Toole, John J. O’Leary. Biomarkers in high grade serous ovarian cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(6) doi: 10.1016/j.bbcan.2024.189224
|
| 146 |
Tomoaki Hara, Sikun Meng, Yasuko Arao, Yoshiko Saito, Kana Inoue, Aya Hasan Alshammari, Hideyuki Hatakeyama, Eric di Luccio, Andrea Vecchione, Takaaki Hirotsu, Hideshi Ishii. Non-Invasive Detection of Tumors by Volatile Organic Compounds in Urine. Biomedicines 2025; 13(1) doi: 10.3390/biomedicines13010109
|
| 147 |
Mengyang Han, Ge Gao, Weiyu Zhao, Yang Liu, Zijia Chen, Xiyan Ye, Lina Qiu, Aijun Gong. Recent advances in biosensors for the detection of pancreatic cancer protein markers. Talanta 2026; 296 doi: 10.1016/j.talanta.2025.128472
|
| 148 |
Fabienne Weber, Aina Valenti, Jiří Ledvinka, Oren Moscovitz, Peter H. Seeberger. Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential. Angewandte Chemie International Edition 2026; 65(39) doi: 10.1002/anie.7795967
|
| 149 |
Ryan Munnings, Peter Gibbs, Belinda Lee. Evolution of Liquid Biopsies for Detecting Pancreatic Cancer. Cancers 2024; 16(19) doi: 10.3390/cancers16193335
|
| 150 |
Qian Wu, Mengqing Sun, Yan Lin, Shujin Lin, Ting Lin, Xiao Han, Xianlin Han. Proposing an Optimized Prediction Model for Pancreatic Cancer Based on Mendelian Randomization Analysis of Fibrinogen Levels and Urinary Protein Excretion Rate. Clinical Medicine Insights: Oncology 2026; 20 doi: 10.1177/11795549251392490
|
| 151 |
Nebojsa Manojlovic, Goran Savic, Bojan Nikolic, Nemanja Rancic. Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy. World Journal of Clinical Cases 2022; 10(3): 899-918 doi: 10.12998/wjcc.v10.i3.899
|
| 152 |
Yizhou Huang, Maohui Chen, Zhenyuan Yang, Yongcong Zhang, Chuanquan Lin, Shuliang Zhang, Taidui Zeng, Jun Yu, Chun Chen, Bin Zheng. Prognostic impact of advanced lung cancer inflammation index and tumor load index in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1724061
|
| 153 |
Christina Jane Vellan, Jaime Jacqueline Jayapalan, Boon-Koon Yoong, Azlina Abdul-Aziz, Sarni Mat-Junit, Perumal Subramanian. Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review. International Journal of Molecular Sciences 2022; 23(4) doi: 10.3390/ijms23042093
|
| 154 |
Athar Nakisa, Lorenzo F. Sempere, Xi Chen, Linda T. Qu, Daniel Woldring, Howard C. Crawford, Xuefei Huang. Tumor‐Associated Carbohydrate Antigen 19–9 (CA 19–9), a Promising Target for Antibody‐Based Detection, Diagnosis, and Immunotherapy of Cancer. ChemMedChem 2024; 19(24) doi: 10.1002/cmdc.202400491
|
| 155 |
Purva Gopal, Marie E. Robert, Xuchen Zhang. Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision Medicine. Archives of Pathology & Laboratory Medicine 2024; 148(3) doi: 10.5858/arpa.2022-0537-RA
|
| 156 |
Andrea Pinkeova, Natalia Kosutova, Eduard Jane, Lenka Lorencova, Aniko Bertokova, Tomas Bertok, Jan Tkac. Medical Relevance, State-of-the-Art and Perspectives of “Sweet Metacode” in Liquid Biopsy Approaches. Diagnostics 2024; 14(7) doi: 10.3390/diagnostics14070713
|
| 157 |
Filbert H. Juwono, W.K. Wong, Hui Ting Pek, Saaveethya Sivakumar, Donata D. Acula. Ovarian cancer detection using optimized machine learning models with adaptive differential evolution. Biomedical Signal Processing and Control 2022; 77 doi: 10.1016/j.bspc.2022.103785
|
| 158 |
Krzysztof Mikolajczyk, Marcin Czerwinski, Radoslaw Kaczmarek. Glycoproteins, Glycolipids, or Both: Why do Glycosyltransferases Recognize Different Acceptors?. ChemBioChem 2025; 26(22) doi: 10.1002/cbic.202500212
|
| 159 |
Zhenghong Le, Shuran Chen, Yan Feng, Weichen Lu, Mulin Liu. SERPINC1, a new prognostic predictor of colon cancer, promote colon cancer progression through EMT. Cancer Reports 2024; 7(6) doi: 10.1002/cnr2.2079
|
| 160 |
Mridula Bhadra, Manisha Sachan, Seema Nara. Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1361601
|
| 161 |
Sai Renuka Chandrasekaran, Dwarithaa Balasubramanian, Abhinand Ponneri Adithavarman, Venkatachalam Deepa Parvathi. Budding Uninhibited by Benzimidazole 1 in pancreatic cancer: theoretical, mechanistic and bioinformatic insights. Egyptian Journal of Medical Human Genetics 2025; 26(1) doi: 10.1186/s43042-025-00809-1
|
| 162 |
Rui-Kyi Ng, Vishal G Shelat. Carbohydrate antigen 72-4 and tumor-associated glycoprotein 72 - tumor marker: Past, present and future. World Journal of Gastrointestinal Pathophysiology 2026; 17(3): 125464 doi: 10.4291/wjgp.125464
|
| 163 |
Ze-mao Li, Wei Zhou, Li Feng, Hui-ying Zhang, Wei-bin Chen. Predictive value of preoperative CT enhancement rate and CT perfusion parameters in colorectal cancer. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03257-0
|
| 164 |
Pratibha Malhotra, Ranjith Palanisamy, Jose A. Caparros-Martin, Marco Falasca. Bile Acids and Microbiota Interplay in Pancreatic Cancer. Cancers 2023; 15(14) doi: 10.3390/cancers15143573
|
| 165 |
Andrey D. Dolbnya, Igor A. Popov, Stanislav I. Pekov. Molecular Biomarkers in Cholangiocarcinoma: Focus on Bile. Current Topics in Medicinal Chemistry 2024; 24(8) doi: 10.2174/0115680266290367240130054142
|
| 166 |
Jihyun Keum, Won Moo Lee, Joong Sub Choi, Jaeman Bae, Seongsil Cho, Bo Kyeong Kang. Diagnostic Clues for Women with Acute Surgical Abdomen Associated with Ruptured Endometrioma. Journal of Personalized Medicine 2023; 13(8) doi: 10.3390/jpm13081226
|
| 167 |
Rui Qi, Xin Wang, Zhidan Kuang, Xueyi Shang, Fang Lin, Dan Chang, Jinsong Mu. Alpha-fetoprotein and carbohydrate antigen 19-9 as prognostic biomarkers in acute liver failure: A retrospective study. Journal of International Medical Research 2025; 53(4) doi: 10.1177/03000605251332808
|
| 168 |
A. Floortje van Oosten, Vincent P. Groot, Galina Dorland, R.A. Burkhart, Christopher L. Wolfgang, Hjalmar C. van Santvoort, Jin He, I. Quintus Molenaar, Lois A. Daamen. Dynamics of Serum CA19-9 in Patients Undergoing Pancreatic Cancer Resection. Annals of Surgery 2024; 279(3) doi: 10.1097/SLA.0000000000005977
|
| 169 |
Noriyuki Kanehira, Fuminori Teraishi, Tomoyuki Tajima, Tatsunori Osone, Kazuyoshi Gotoh, Takuya Fujimoto, Yoshinori Sakurai, Natsuko Kondo, Narikazu Nagahisa, Kaoru Kamei, Taiga Fujita, Akira Morihara, Yutaka Takaguchi, Mizuki Kitamatsu, Takeshi Takarada, Kunitoshi Shigeyasu, Minoru Suzuki, Toshiyoshi Fujiwara, Hiroyuki Michiue. Tumor marker–guided precision BNCT for CA19-9–positive cancers: a new paradigm in molecularly targeted chemoradiation therapy. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-07349-7
|
| 170 |
Mohamed Badheeb, Adham Abdelrahim, Abdullah Esmail, Godsfavour Umoru, Karen Abboud, Ebtesam Al-Najjar, Ghaith Rasheed, Mohammed Alkhulaifawi, Ala Abudayyeh, Maen Abdelrahim. Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening. Current Oncology 2022; 29(11) doi: 10.3390/curroncol29110686
|
| 171 |
Ashok Kumar Balaraman, Ehssan Moglad, Muhammad Afzal, M Arockia Babu, Kavita Goyal, R. Roopashree, Irwanjot Kaur, Sachin Kumar, MRavi Kumar, Ashish Singh Chauhan, S. Hemalatha, Gaurav Gupta, Haider Ali. Liquid biopsies and exosomal ncRNA: Transforming pancreatic cancer diagnostics and therapeutics. Clinica Chimica Acta 2025; 567 doi: 10.1016/j.cca.2024.120105
|
| 172 |
Vinit Sharma, Ankita Semwal, Shivangani Lohani, Ankita Arora, Sakshi Bansal, Mayank Sharma, Rajesh Gupta, Harjeet Singh, Anjali Aggarwal. Potential of circulating miR-6875 and miR-1307 as non-invasive diagnostic biomarkers for pancreatic cancer. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03490-3
|
| 173 |
Rishaan Pawaskar, Kevin Zhang Huang, Helen Pham, Adnan Nagrial, Mark Wong, Siobhan O’Neill, Henry Pleass, Lawrence Yuen, Vincent W. T. Lam, Arthur Richardson, Tony Pang, Christopher B. Nahm. Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma. Cancers 2024; 16(4) doi: 10.3390/cancers16040698
|
| 174 |
Peng Son, Fen Yeong Chen, Jun Er Chin Benedick, Ruiling Hui, Simin Guo. Clonorchiasis misdiagnosed as hepatic space-occupying lesion: a case report. Diagnostic Microbiology and Infectious Disease 2025; 113(4) doi: 10.1016/j.diagmicrobio.2025.117027
|
| 175 |
Clara Isabel Moreno, Javier Miguel Ortega. Precision Boron Neutron Capture Therapy for CA19-9–Expressing Cancers: A Tumor Marker–Guided Approach. Journal of Medical Sciences and Interdisciplinary Research 2022; 2(2) doi: 10.51847/DOVY9ncwra
|
| 176 |
James Sun, Morcos A. Awad, Jennifer Hwang, Anthony M. Villano. Molecular Biomarkers for the Diagnosis and Prognostication of Pancreatic Ductal Adenocarcinoma. Journal of Personalized Medicine 2025; 15(6) doi: 10.3390/jpm15060236
|
| 177 |
Violetta Rosiek, Agnes Bocian-Jastrzębska, Beata Kos-Kudła. Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome. Cancers 2023; 15(8) doi: 10.3390/cancers15082348
|
| 178 |
Aminath Rana Abdul Rasheed, Rhun Yian Koh, Wei-Meng Lim, Chun-Wai Mai, Chin-King Looi. Catching pancreatic cancer early: Are we there yet?. Journal of the National Cancer Center 2026; 6(2) doi: 10.1016/j.jncc.2025.12.001
|
| 179 |
Lois Riobó-Mayo, Lluis Salvador, Alex Teulé, Elisabet Guinó, Laura Layos, Serena Oliveri, Clizia Cincidda, Giulia Ongaro, Chiara A Accornero, Chiara Alessandra Cella, Lorenzo Gervaso, Nicola Fazio, Paul E Summers, Giuseppe Petralia, Cindy Canivet, Barbara Bournet, Louis Buscail, Andrei Roman, Loredana Balacescu, Adrian Trifa, Andreea Catana, Florina Pop, Ovidiu Balacescu, Patrycja Przybyłowicz, Olga Taryma-Lesniak, Tomasz K Wojdacz, Mireia Obón-Santacana, Victor Moreno. Development and validation of an epidemiological risk score for early detection of pancreatic cancer in high-risk individuals within the IMAGene project. International Journal of Epidemiology 2026; 55(3) doi: 10.1093/ije/dyag064
|
| 180 |
Eyad Gadour, Stefano Francesco Crinò, Marco Spadaccini, Antonio Facciorusso. Diagnostic and therapeutic strategies for biliary strictures: a comparison of ACG, ESGE, and ASGE guidelines. Expert Review of Gastroenterology & Hepatology 2026; 20(1) doi: 10.1080/17474124.2025.2592076
|
| 181 |
Ryuichiro Sato, Masaya Oikawa, Tetsuya Kakita, Tomoya Abe, Naoya Akazawa, Haruka Okano, Kei Ito, Takashi Tsuchiya. Prognostic value of carcinoembryonic antigen (CEA) and CA 19-9 levels in patients with obstructive colorectal cancer treated with a self-expandable metallic stent and curative surgery. Surgery Today 2025; 55(5) doi: 10.1007/s00595-024-02943-6
|
| 182 |
Yuichiro Onuki, Hirochika Matsubara, Ryunosuke Koizumi, Mamoru Muto, Harunobu Sasanuma, Daisuke Sato, Aya Sugimura, Tsuyoshi Uchida, Hiroyasu Matsuoka, Hiroyuki Nakajima. Prognostic evaluation of preoperative serum tumor marker‐negative cases in non‐small cell lung cancer: A retrospective study. Cancer Reports 2023; 6(2) doi: 10.1002/cnr2.1696
|
| 183 |
Jakub Ciesielka, Krzysztof Jakimów, Natalia Tekiela, Laura Peisert, Anna Kwaśniewska, Dariusz Kata, Jerzy Chudek. Significantly Elevated CA 19-9 after COVID-19 Vaccination and Literature Review of Non-Cancerous Cases with CA 19-9 > 1000 U/mL. Journal of Clinical Medicine 2024; 13(5) doi: 10.3390/jcm13051263
|
| 184 |
Paweł B. Podgórski, Adam Przybyłkowski, Piotr Nehring, Olga Ciepiela. Biliary Concentration of Carbohydrate Antigen 19-9 and Cancer Antigen 125, Iron Metabolism Markers, and PIVKA-II Activity in Pancreatobiliary Tumors. Digestive Diseases 2025; 44(1) doi: 10.1159/000549784
|
| 185 |
Yuqi Zhang, Abdullah Esmail, Hala Hassanain, Vikramjit Dhillon, Waseem Abdelrahim, Ebtesam Al-Najjar, Bayan Khasawneh, Maen Abdelrahim. Correlative Analysis of Tumor-Informed Circulating Tumor DNA (ctDNA) and the Survival Outcomes of Patients with Pancreatic Adenocarcinoma. Biomedicines 2025; 13(5) doi: 10.3390/biomedicines13051124
|
| 186 |
Deya' Aldeen Sweedat, Saad Ruzzeh, Ahmed Saad Abdlkadir, Serin Moghrabi, Marwah Abdulrahman, Akram Al-Ibraheem. Fibroblast Activation Protein-Targeted Radioligand Therapy (FAP RLT) in Gastroenteropancreatic Malignancies: Biological Rationale, Clinical Evidence, and Future Directions. World Journal of Nuclear Medicine 2026; 25(01) doi: 10.1055/s-0046-1820110
|
| 187 |
Xiaohui Wang, Yu Liu, Bude Su, Jinhua Tan, Jianxin Shen, Qi Chen, Yu Gou, Ying Zhang. Efficient electrochemical detection of pancreatic cancer marker CA19-9 using biosynthesized gold nanoparticles from mint extract for electrode modification. Alexandria Engineering Journal 2025; 118 doi: 10.1016/j.aej.2025.01.083
|
| 188 |
Ingrid Garajová, Marianna Peroni, Fabio Gelsomino, Francesco Leonardi. A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists. Current Oncology 2023; 30(11) doi: 10.3390/curroncol30110694
|
| 189 |
Axel Bengtsson, Roland Andersson, Johan Linders, Aiste Gulla, Daniel Ansari. Biomarkers for Early Detection of Pancreatic Cancer. Visceral Medicine 2025; 41(5) doi: 10.1159/000546584
|
| 190 |
Violetta Rosiek, Ksenia Janas, Magdalena Witkowska, Beata Kos-Kudła. Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms. Journal of Clinical Medicine 2023; 12(14) doi: 10.3390/jcm12144687
|
| 191 |
Ewa Grudzińska, Magdalena Gajda, Sławomir Mrowiec. Association of neoadjuvant chemotherapy with outcomes in patients with elevated preoperative Ca 19–9 undergoing pancreatic ductal adenocarcinoma resection. Expert Review of Anticancer Therapy 2026; doi: 10.1080/14737140.2026.2699780
|
| 192 |
Xiaolei Zhou. Meta-analysis of the diagnostic performance of serum carbohydrate antigen 19-9 for the detection of gallbladder cancer. The International Journal of Biological Markers 2022; 37(1) doi: 10.1177/17246008211068866
|
| 193 |
Esra Zeynelgil, Serkan Gülcü, Abdülkadir Koçanoğlu, Yakup Düzköprü, Gökşen İnanç İmamoğlu, Tülay Eren. Prognostic Value of Inflammatory Markers, CA 19-9, MELD Score, and ECOG in Stage 4 Gastric Cancer with Liver Metastases. Acta Haematologica Oncologica Turcica 2025; doi: 10.4274/ahot.galenos.2025.2025-5-4
|
| 194 |
Jie Liang, William G. Tong. Sensitive detection of surface-mounted micrometer-thin cancer biomarkers and viruses using laser wave-mixing spectroscopy. Biomedical Optics Express 2026; 17(8) doi: 10.1364/BOE.604794
|
| 195 |
Alfonso Agüera-Sánchez, Emilio Peña-Ros, Irene Martínez-Martínez, Francisco García-Molina. Comprehensive Landscape of Diagnostic, Prognostic and Predictive Biomarkers in Colorectal Cancer: From Genomics to Multi-Omics Integration in Precision Medicine. Journal of Personalized Medicine 2026; 16(1) doi: 10.3390/jpm16010048
|
| 196 |
Štefan Sotak. Cholestasis and Carcinoma of the Ureter: Stauffer Syndrome?. Vnitřní lékařství 2025; 71(4) doi: 10.36290/vnl.2025.050
|
| 197 |
Somayyeh Hormaty, Anwar Nather Seiwan, Bushra H. Rasheed, Hanieh Parvaz, Ali Gharahzadeh, Hamid Ghaznavi. A Review on Biomarker‐Enhanced Machine Learning for Early Diagnosis and Outcome Prediction in Ovarian Cancer Management. Cancer Medicine 2025; 14(17) doi: 10.1002/cam4.71224
|
| 198 |
Bernard Jonathan Christian Yong, Made Wirama Diyana. Low Carbohydrate Antigen 19-9 (CA 19-9) Levels in a Patient Highly Suspected of Having Caput Pancreas Tumor. Cureus 2022; doi: 10.7759/cureus.24357
|
| 199 |
S. Tan, M. Machrumnizar. Fish and Food-Fatale: Food-borne Trematode Opisthorchis viverrini and Cholangiocarcinoma. Helminthologia 2023; 60(4) doi: 10.2478/helm-2023-0036
|
| 200 |
Kylie Prutisto-Chang, Tigist Batu, Faezeh Jame-Chenarboo, Eva Hernando, Lara K. Mahal. Glycosylation in Cancer: From Functional Roles to Therapeutic Implications.
Annual Review of Cancer Biology
2026; 10(1) doi: 10.1146/annurev-cancerbio-060625-123845
|
| 201 |
Aditya V. Shreenivas, Shumei Kato, Jingjing Hu, Catherine Skefos, Jason Sicklick, Razelle Kurzrock. Carcinoma of unknown primary: Molecular tumor board‐based therapy. CA: A Cancer Journal for Clinicians 2022; 72(6) doi: 10.3322/caac.21748
|
| 202 |
Mohammed A. Akeel, Ekramy M. Elmorsy, Fahad M. Alshammari, Aly A. M. Shaalan, Abdulrahman S. Aldaghmi, Barakat M. Alrashdi, Saad M. Alrashidi, Gehad E. Elshopakey, Baraah Abu Alsel, Manal S. Fawzy. Liposomal Morin Attenuates DMH-Associated Colonic Oxidative Stress, Inflammation, and Apoptosis/Autophagy-Related Dysregulation in Rats. Pharmaceuticals 2026; 19(9) doi: 10.3390/ph19091400
|
| 203 |
Jonathan G. A. Koo, Hui Yu Tham, En Qi Toh, Christopher Chia, Amy Thien, Vishal G. Shelat. Mirizzi Syndrome—The Past, Present, and Future. Medicina 2023; 60(1) doi: 10.3390/medicina60010012
|
| 204 |
Rui Chen, Zhengli Zhou, Qihua Dang, Changjing Zuo, Tao Wang. High expression of Testin predicted worse prognosis in pancreatic adenocarcinoma associated with immune infiltration. Molecular & Cellular Toxicology 2025; 21(3) doi: 10.1007/s13273-024-00448-4
|
| 205 |
Role of Biomarkers in Cancer Diagnosis and Therapeutics. 2026; doi: 10.1016/B978-0-443-44041-0.00025-8
|
| 206 |
Janine C. Quijano, Honoka Natsuyama, Alonso Tapia, Karine Bagramyan, Jose A. Ortiz, Jacob Mares, Markus Kalkum, Yoko Fujita-Yamaguchi, Hsun Teresa Ku. A lectin produced by a Streptomyces species targets mammalian pancreatic acinar cells in mice and humans. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-024-80889-y
|
| 207 |
Lu Chen, Sheng Hu, Lixin Liu, Siheng He, Huabing Fan, Feng Shao, Lianghua Li, Xiaowen Zhang. Prognostic value of preoperative serum ferritin in cholangiocarcinoma patients. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-27989-5
|
| 208 |
Ji Ha Lim, Jung Wook Huh, Woo Yong Lee, Seong Hyeon Yun, Hee Cheol Kim, Yong Beom Cho, Yoon Ah Park, Jung Kyong Shin. Comparison of Long-Term Survival Outcomes of T4a and T4b Colorectal Cancer. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.780684
|
| 209 |
Mathias H. Gramkow, Camilla S. Mosgaard, Jakob V. Schou, Ellen Hein Nordvig, Troels Gammeltoft Dolin, Jakob Lykke, Dorte L. Nielsen, Per Pfeiffer, Camilla Qvortrup, Mette K. Yilmaz, Ole Larsen, Stig E. Bojesen, Benny V. Jensen, Julia S. Johansen. The prognostic role of circulating CA19–9 and CEA in patients with colorectal cancer. Cancer Treatment and Research Communications 2025; 43 doi: 10.1016/j.ctarc.2025.100907
|
| 210 |
Melissa Heller, Derek A. Mann, Bryson W. Katona. Current Approaches of Pancreatic Cancer Surveillance in High-Risk Individuals. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-025-01184-1
|
| 211 |
Daniel Keefe, Rasheid Smith, Bingtao Gao, Walla I. Malkawi, Sean M. Geary, Pashtoon M. Kasi, Saima Sharif, Aliasger K. Salem, Fatima Toor. Colorectal Cancer Biosensor Using Vertically-Oriented Silicon Nanowires. 2022 IEEE Sensors 2022; doi: 10.1109/SENSORS52175.2022.9967069
|
| 212 |
Niloofar Asadi Hanjani, Nazanin Esmaelizad, Saba Zanganeh, Abdulwahab Teflischi Gharavi, Pegah Heidarizadeh, Maryam Radfar, Fateme Omidi, Ronan MacLoughlin, Mohammad Doroudian. Emerging role of exosomes as biomarkers in cancer treatment and diagnosis. Critical Reviews in Oncology/Hematology 2022; 169 doi: 10.1016/j.critrevonc.2021.103565
|
| 213 |
Kunal Hiwase, Prateek Verma, Nikita Zade, Praveen Kumar, Induni Nayodhara Weerarathna, Swapnil Gundewar. A Review on the Applications and Implications of Artificial Intelligence and Machine Learning in Oncology. International Journal of Computational Intelligence Systems 2026; 19(1) doi: 10.1007/s44196-026-01164-8
|
| 214 |
Shuuji Mawaribuchi, Osamu Shimomura, Tatsuya Oda, Keiko Hiemori, Kayoko Shimizu, Kenya Yamase, Mutsuhiro Date, Hiroaki Tateno. rBC2LCN-reactive SERPINA3 is a glycobiomarker candidate for pancreatic ductal adenocarcinoma. Glycobiology 2023; 33(4) doi: 10.1093/glycob/cwad009
|
| 215 |
Zhicong Wang, Yabo Shi, Ganwei Xiong, Mengxi Han, Xiaoliang Chen. The prognostic impact of preoperative CA19-9 on resectable cholangiocarcinoma: a comprehensive systematic review and meta-analysis. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01683-w
|
| 216 |
Zhonghua Wu, Fanyong Zhang. Serum CEA, CA19-9, and AFP as biomarkers for gastric cancer. Journal of Medical Biochemistry 2026; 45(1) doi: 10.5937/jomb0-58684
|
| 217 |
Role of Biomarkers in Cancer Diagnosis and Therapeutics. 2026; doi: 10.1016/B978-0-443-44041-0.00023-4
|
| 218 |
Neeraj Patel, Aditi Gupta, Riya Mishra, Soumya V. Menon, Subhashree Ray, Surya Nath Pandey, Kavita Goyal, Haider Ali, Chandana Maji, A. Rekha, Gaurav Gupta, Md Sadique Hussain. Mesothelin in pancreatic cancer: clinical applications and analytical considerations. Clinica Chimica Acta 2026; 579 doi: 10.1016/j.cca.2025.120686
|
| 219 |
Noha Said Helal, Sara Maher, Safia Samir, Hesham A. Elmeligy, Mohammed A. Aboul-Ezz, Tarek Aboushousha, Mona Moussa. Assessing the diagnostic potential of SATB2 and β-catenin as biomarkers and therapeutic targets in pancreatic ductal adenocarcinoma. Journal of Cancer Research and Clinical Oncology 2025; 151(2) doi: 10.1007/s00432-024-06055-z
|
| 220 |
Peng Ge, Yalan Luo, Haiyang Chen, Jiayue Liu, Haoya Guo, Caiming Xu, Jialin Qu, Guixin Zhang, Hailong Chen. Application of Mass Spectrometry in Pancreatic Cancer Translational Research. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.667427
|
| 221 |
Valentina Giansante, Gianmarco Stati, Silvia Sancilio, Emanuela Guerra, Saverio Alberti, Roberta Di Pietro. The Dual Role of Necroptosis in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2023; 24(16) doi: 10.3390/ijms241612633
|
| 222 |
Zhimao Chen, Yaokun Wang, Minghui Shi, Kang Qi, Xiangzheng Liu, Shijie Zhang. Risk factors and predictive model of lymph node metastasis in clinical stage IA peripheral non-small cell lung cancer: a retrospective study. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-15076-x
|
| 223 |
Sanna Matilainen, Hanna Liikanen, Riitta Lassila, Minna K. Laitinen. Assessing the diagnostic value of oncological biomarkers for identifying primary malignancies in skeletal metastatic disease. European Journal of Surgical Oncology 2025; 51(6) doi: 10.1016/j.ejso.2025.109688
|
| 224 |
Simranjit Kaur, Chrystal Huynh, Victoria Pan, Khalid Hirmiz. Complete Remission After Palliative Radiation and Chemotherapy in Stage IV BRCA1-Positive Pancreatic Cancer: A Case of a Patient Who Was Cured 11 Years After Treatment. Cureus 2025; doi: 10.7759/cureus.98008
|
| 225 |
Guolin Yin, Miaomiao Zhang, Bing Zhao, Zaixing Yang. High serum levels of CA 19-9 and CYFRA21-1 caused by renal pelvis urothelial carcinoma: a report of two cases. Journal of International Medical Research 2021; 49(3) doi: 10.1177/03000605211002692
|
| 226 |
Amy Makler, Waseem Asghar. Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study. International Journal of Molecular Sciences 2023; 24(6) doi: 10.3390/ijms24065081
|
| 227 |
Fahmy T. Ali, Reham M. Soliman, Nahla S. Hassan, Ahmed M. Ibrahim, Mayada M. El-Gizawy, Abd Allah Y. Mandoh, Ehab A. Ibrahim, Elizabeth Christie. Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer. PLOS ONE 2022; 17(8) doi: 10.1371/journal.pone.0272308
|
| 228 |
Terence Moyana, Valeria Merz. Editorial: Molecular markers for pancreatic cancers: new technologies and applications in the clinical practice. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1651566
|
| 229 |
Biaoming Xu, Yu Chen, Mingjing Peng, Jin Hai Zheng, Chaohui Zuo. Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma. International Journal of Cancer 2023; 152(2) doi: 10.1002/ijc.34195
|
| 230 |
Valeria Tonini, Manuel Zanni. Early diagnosis of pancreatic cancer: What strategies to avoid a foretold catastrophe. World Journal of Gastroenterology 2022; 28(31): 4235-4248 doi: 10.3748/wjg.v28.i31.4235
|
| 231 |
Rohit Pujari, Shiv Kumar Dubey. Relevance of glyco-biomakers and glycan profiles in cancer stem cells. Glycobiology 2024; 34(6) doi: 10.1093/glycob/cwad019
|
| 232 |
Ashlyn McConnell, Tyler Stoneman, Stanley Hewlett. Extraordinarily high serum CA 19-9 in setting of pancreatic necrosis and underlying pancreatic adenocarcinoma: a case report. Journal of Surgical Case Reports 2023; 2023(10) doi: 10.1093/jscr/rjad550
|
| 233 |
Nasser Mousa, Alaa Elmetwalli, Othman R. Alzahrani, Mohamed A. Shahin, Ahmed Mohamed El Nakib, Eman Abdelkader, Ola El-Emam, Marwa Mansour, Mostafa Abdelsalam, Khulood Fahad Alabbosh, Dalia Wael, Ali El-Far, Jihan Hassan. Molecular docking insights into miR-155 and VEGF synergy: colorectal cancer detection through AI-enhanced integration of molecular biomarkers and clinical risk assessment. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-03348-y
|
| 234 |
Yuki Shimizu, Shintaro Kanda, Toshirou Fukushima, Takashi Kobayashi, Ryoichi Kondo, Tomonobu Koizumi. Increased carbohydrate antigen 19‐9 expression in a thymic neuroendocrine tumor. Thoracic Cancer 2021; 12(21) doi: 10.1111/1759-7714.14153
|
| 235 |
Aleksander M. Bogdanski, Jeanin E. van Hooft, Bas Boekestijn, Bert A. Bonsing, Martin N. J. M. Wasser, Derk C. F. Klatte, Monique E. van Leerdam. Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. Familial Cancer 2024; 23(3) doi: 10.1007/s10689-024-00368-1
|
| 236 |
Jacob E. Till, Lee McDaniel, Changgee Chang, Qi Long, Shannon M. Pfeiffer, Jaclyn P. Lyman, Lacey J. Padrón, Deena M. Maurer, Jia Xin Yu, Christine N. Spencer, Pier Federico Gherardini, Diane M. Da Silva, Theresa M. LaVallee, Charles Abbott, Richard O. Chen, Sean M. Boyle, Neha Bhagwat, Samuele Cannas, Hersh Sagreiya, Wenrui Li, Stephanie S. Yee, Aseel Abdalla, Zhuoyang Wang, Melinda Yin, Dominique Ballinger, Paul Wissel, Jennifer Eads, Thomas Karasic, Charles Schneider, Peter O’Dwyer, Ursina Teitelbaum, Kim A. Reiss, Osama E. Rahma, George A. Fisher, Andrew H. Ko, Zev A. Wainberg, Robert A. Wolff, Eileen M. O’Reilly, Mark H. O’Hara, Christopher R. Cabanski, Robert H. Vonderheide, Erica L. Carpenter. Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-49915-5
|
| 237 |
Delin Ma, Pengcheng Wei, Hengkang Liu, Jialing Hao, Zhuomiaoyu Chen, Yingming Chu, Zuyin Li, Wenzai Shi, Zhigao Yuan, Qian Cheng, Jie Gao, Jiye Zhu, Zhao Li. Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinoma. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05854-9
|
| 238 |
Xiaoguang Dong, Boyang Xiao, Hieu Vu, Honglu Lin, Metin Sitti. Millimeter-scale soft capsules for sampling liquids in fluid-filled confined spaces. Science Advances 2024; 10(35) doi: 10.1126/sciadv.adp2758
|
| 239 |
Michael J. Shen, Arsia Jamali, Bryson W. Katona. Challenges of early detection of pancreatic cancer. Journal of Clinical Investigation 2025; 135(20) doi: 10.1172/JCI191942
|
| 240 |
Francesco Muraca, Fausto Gueths Gomes, Gustavo Marçal Schmidt Garcia Moreira, Matthias Ocker. Handbook of Cancer and Immunology. 2024; doi: 10.1007/978-3-030-80962-1_405-1
|
| 241 |
Shaurya Dhingra, Puneet Raman, Taylor Ramsaroop, Isaiah Harrison, Tova Bergsten, Erin Nusbaum, Lawrence E. Feldman. Elevated serum CA 19–9 level mimicking pancreaticobiliary carcinoma from a hepatic abscess: case report and literature review. Frontiers in Medicine 2025; 11 doi: 10.3389/fmed.2024.1470046
|
| 242 |
Rashmi Bangarh, Chainika Khatana, Simranjeet Kaur, Anchita Sharma, Ankur Kaushal, Samarjeet Singh Siwal, Hardeep Singh Tuli, Kuldeep Dhama, Vijay Kumar Thakur, Reena V. Saini, Adesh K. Saini. Aberrant protein glycosylation: Implications on diagnosis and Immunotherapy. Biotechnology Advances 2023; 66 doi: 10.1016/j.biotechadv.2023.108149
|
| 243 |
Suparat Cotchim, Supatinee Kongkaew, Panote Thavarungkul, Proespichaya Kanatharana, Warakorn Limbut. A dual-electrode label-free immunosensor based on in situ prepared Au–MoO3-Chi/porous graphene nanoparticles for point-of-care detection of cholangiocarcinoma. Talanta 2024; 272 doi: 10.1016/j.talanta.2024.125755
|
| 244 |
Yanjun Sun, Junfeng Gong, Zhuang Li, Lin Han, Dengqun Sun. Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy. Postgraduate Medicine 2024; 136(3) doi: 10.1080/00325481.2024.2345585
|
| 245 |
Faisal Saud Dar, Zaigham Abbas, Irfan Ahmed, Muhammad Atique, Usman Iqbal Aujla, Muhammad Azeemuddin, Zeba Aziz, Abu Bakar Hafeez Bhatti, Tariq Ali Bangash, Amna Subhan Butt, Osama Tariq Butt, Abdul Wahab Dogar, Javed Iqbal Farooqi, Faisal Hanif, Jahanzaib Haider, Siraj Haider, Syed Mujahid Hassan, Adnan Abdul Jabbar, Aman Nawaz Khan, Muhammad Shoaib Khan, Muhammad Yasir Khan, Amer Latif, Nasir Hassan Luck, Ahmad Karim Malik, Kamran Rashid, Sohail Rashid, Mohammad Salih, Abdullah Saeed, Amjad Salamat, Ghias-un-Nabi Tayyab, Aasim Yusuf, Haseeb Haider Zia, Ammara Naveed. National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma. World Journal of Gastroenterology 2024; 30(9): 1018-1042 doi: 10.3748/wjg.v30.i9.1018
|
| 246 |
Sheng-Ting Hung, Cheng-Yan Lee, Chen-Yu Lien, Cheng-Hsuan Chan, Ya-Han Yang, Chen-Wei Li, Ting-Han Lee, Hao-Min Huang, Yi-Ling Jian, Tung-Yuan Yu, Chien-Chung Hsu, Quark Yungsung Chen, Kuang-Hung Cheng, Kung-Kai Kuo, Li-Wei Tu, Ching-Wen Chang. Feasibility of KRASG12D Mutant Protein Detection for Pancreatic Cancer Using an AlGaN/GaN HEMT Biosensor. IEEE Sensors Journal 2026; 26(8) doi: 10.1109/JSEN.2026.3669133
|
| 247 |
Alessandro Canella, Zachary Gentry, Casey Cosgrove. The Dickkopf-1 (DKK1) Dichotomy in Oncology: New Insights on Tumor Progression and Immune Regulation. International Journal of Molecular Sciences 2026; 27(9) doi: 10.3390/ijms27093780
|
| 248 |
Tiffany Williams, Raymond Hayler, Celine Garrett, Shoma Barat, Ruwanthi Wijayawardana, Nima Ahmadi, Winston Liauw, David Morris. Impact of diaphragmatic intervention in cytoreductive surgery with heated intraperitoneal chemotherapy for colorectal carcinoma. European Journal of Surgical Oncology 2025; 51(10) doi: 10.1016/j.ejso.2025.110306
|
| 249 |
Abhishek K Singh, Tobi Oputa, Muhammad Z Tariq. Pathological Subtrochanteric Femoral Fracture as the Initial Presentation of Metastatic Thyroid Carcinoma in a Young Adult: A Diagnostic Challenge. Cureus 2026; doi: 10.7759/cureus.105431
|
| 250 |
José Donizeti de MEIRA-JÚNIOR, Thiago Nogueira COSTA, Andre Luis MONTAGNINI, Sergio Carlos NAHAS, Jose JUKEMURA. ELEVATED CA 19-9 IN AN ASYMPTOMATIC PATIENT: WHAT DOES IT MEAN?. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2022; 35 doi: 10.1590/0102-672020220002e1687
|
| 251 |
Di Wang, Valeriia Kuzyk, Katarina Madunić, Tao Zhang, Oleg A. Mayboroda, Manfred Wuhrer, Guinevere S. M. Lageveen-Kammeijer. In-Depth Analysis of the N-Glycome of Colorectal Cancer Cell Lines. International Journal of Molecular Sciences 2023; 24(5) doi: 10.3390/ijms24054842
|
| 252 |
Elena I. Dyachenko, Lyudmila V. Bel’skaya. How Does Breast Cancer Heterogeneity Determine Changes in Tumor Marker Levels in Saliva?. Current Issues in Molecular Biology 2025; 47(4) doi: 10.3390/cimb47040216
|
| 253 |
Yuan Lin, Hailong Zhu, Dan Zhang, Jinbi Xie, Mengjing Pan, Shanjuan Wang. Colonoscopy-detected high-risk adenomas and their association with alcohol consumption among first-degree relatives: an observational case–control study. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1791247
|
| 254 |
Dan Li, Jianfeng Qian, Yanrong Li, Yibin Liu, Xiankui Xu, Xue Zhou, Zhonghai Zhang, Jun Meng, Kai Qin. Single-atom aptamer anchoring enables light-addressable multiplexed biosensing for early detection of pancreatic cancer. Biosensors and Bioelectronics 2025; 288 doi: 10.1016/j.bios.2025.117792
|
| 255 |
Taku Yamada, Taichi Minami, Masayo Yamada, Yasuo Terauchi. Proposed carbohydrate antigen 19-9 (CA19-9) cut-off values for the detection of pancreatic cancer in patients with poorly controlled diabetes: a real-world study. Endocrine Journal 2023; 70(11) doi: 10.1507/endocrj.EJ23-0186
|
| 256 |
Ashwini S. Sanji, Manasa J., Maruti J. Gurav, Surinder K. Batra, Vishwanath B. Chachadi. Cancer snap-shots: Biochemistry and glycopathology of O-glycans: A review. International Journal of Biological Macromolecules 2024; 260 doi: 10.1016/j.ijbiomac.2024.129318
|
| 257 |
Mizuki Endo, Shin Yazawa, Rie Sano, Takehiko Yokobori, Ken Shirabe, Hiroshi Saeki. α1-Acid Glycoprotein with Highly Fucosylated Glycans as a Potential Diagnostic Marker for Early Detection of Hepatobiliary and Pancreatic Cancers. Diagnostics 2024; 15(1) doi: 10.3390/diagnostics15010040
|
| 258 |
Naga Sai Rasagna Mareddy, Mohana Chakkera. Immune Therapy for Pancreatic and Colon Cancers. 2025; doi: 10.1016/B978-0-443-24742-2.00016-2
|
| 259 |
Keita Tashiro, Yoshiki Kajiwara, Hideki Ueno, Hirotoshi Kobayashi, Kenjiro Kotake, Kenichi Sugihara, Yoichi Ajioka. Preoperative carbohydrate antigen 19-9 as a prognostic biomarker in colorectal cancer with synchronous peritoneal metastasis: multicentre cohort study. BJS Open 2026; 10(3) doi: 10.1093/bjsopen/zrag060
|
| 260 |
Guitao Bai, Tangliang Shen, MohammadHossein Shabahang, Shumin Bao, Shuquan Fan, Hongshuai Lv, Lei Li. Divergent Enzymatic Synthesis of a Comprehensive Type-1 Glycan Determinant Library. ACS Catalysis 2025; 15(24) doi: 10.1021/acscatal.5c06702
|
| 261 |
Ashley Lauren Hein, Erika Hissong. Advancements and challenges in biomarker testing for tumors of the luminal gastrointestinal tract: current practice guidelines and emerging markers. Diagnostic Histopathology 2025; 31(6) doi: 10.1016/j.mpdhp.2025.03.011
|
| 262 |
Iris J. M. Levink, Sanne C. Jaarsma, Brechtje D. M. Koopmann, Priscilla A. van Riet, Kasper A. Overbeek, Jihane Meziani, Marloes L. J. A. Sprij, Riccardo Casadei, Carlo Ingaldi, Marcin Polkowski, Megan M. L. Engels, Laurens A. van der Waaij, Silvia Carrara, Elizabeth Pando, Marlies Vornhülz, Pieter Honkoop, Erik J. Schoon, Johanna Laukkarinen, Jilling F. Bergmann, Gemma Rossi, Frederike G. I. van Vilsteren, Anne‐Marie van Berkel, Trevor Tabone, Matthijs P. Schwartz, Adriaan C. I. T. L. Tan, Jeanin E. van Hooft, Rutger Quispel, Ellert van Soest, Laszlo Czacko, Marco J. Bruno, Djuna L. Cahen. The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program. United European Gastroenterology Journal 2023; 11(7) doi: 10.1002/ueg2.12422
|
| 263 |
Jiarong Shang, Jin Zhu, Xia Zheng, Yujia Shao, Jun Qian, Yong Li, Ping Wang. Distant metastasis risk and prognosis in elderly gastric cancer patients after neoadjuvant chemotherapy and surgery. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1757874
|
| 264 |
Lan Wang, Ming Li, Tiantian Dong, Yuanyuan Li, Ci Yin, Fang Nie. Pancreatic Ductal Adenocarcinoma: The Characteristics of Contrast-Enhanced Ultrasound Are Correlated with the Hypoxic Microenvironment. Diagnostics 2023; 13(20) doi: 10.3390/diagnostics13203270
|
| 265 |
Yuri Choi, Jae Hyun Park, Ala Jo, Chul-Woo Lim, Ji-Min Park, Jin Woo Hwang, Kang Soo Lee, Young-Sang Kim, Hakho Lee, Jisook Moon.
Blood-derived APLP1
+
extracellular vesicles are potential biomarkers for the early diagnosis of brain diseases
. Science Advances 2025; 11(1) doi: 10.1126/sciadv.ado6894
|
| 266 |
Sowbharnika Arivazhagan, Deepti Kantamani, Natalee E Tanner, Madappa N Kundranda, M. Patrick Stagg. Infection Masquerading as Recurrence of Pancreatic Ductal Adenocarcinoma: A Cautionary Tale. Cureus 2021; doi: 10.7759/cureus.17010
|
| 267 |
Wenwen Wang, Guo Chen, Wenli Zhang, Xihua Zhang, Manli Huang, Chen Li, Ling Wang, Zifan Lu, Jielai Xia. The crucial prognostic signaling pathways of pancreatic ductal adenocarcinoma were identified by single-cell and bulk RNA sequencing data. Human Genetics 2024; 143(9-10) doi: 10.1007/s00439-024-02663-4
|
| 268 |
Hui Zhou, Qingqing Guo, Xin Zhang, Tingting Chu, Wen Zhang, Qing Liu, Linlin Cao. Ultrasensitive photoelectrochemical immunosensor based on floral cluster SnS2/ZnCdS heterostructure for the detection of CA199. Frontiers in Bioengineering and Biotechnology 2025; 13 doi: 10.3389/fbioe.2025.1584456
|
| 269 |
Gurudutt P. Varty, Shraddha Patkar, Mufaddal Kazi, Karthik Velmurugan, Amita Sekhar Padhy, Baskaran Dhanapal, Sujat Lele, Snigdha Kamini, Abdeali Saif Arif Kaderi, Akash Pawar, Subhash Yadav, Shivakumar Gudi, Kunal B. Gala, Prabhat Bhargava, Anant Ramaswamy, Vikas Ostwal, Mahesh Goel. Development of a novel predictive nomogram to prevent ‘futile surgery’ in gallbladder cancers: A single center analysis of 1196 resected gallbladder cancers. European Journal of Surgical Oncology 2025; 51(12) doi: 10.1016/j.ejso.2025.110492
|
| 270 |
坚伟 肖. Application of Traditional Serum Tumor Markers and Circulating Tumor DNA in Colorectal Cancer. Advances in Clinical Medicine 2026; 16(08) doi: 10.12677/acm.2026.1682960
|
| 271 |
Jiahuang Huang, Jingjing Hu, Wei Zhang, Dayong Sun, Donghai Wu, Jingbo Yang. Progressive CA19-9 elevation with normal bilirubin as an escalation signal in pseudocyst-like pancreatic ductal adenocarcinoma. Pancreatology 2026; 26(5) doi: 10.1016/j.pan.2026.06.003
|
| 272 |
Makoto Takeda, Yoshinori Onuki, Kosuke Oishi, Osamu Kubota, Takashi Uchiyama, Yoshifumi Arai, Hiroya Takeuchi. Giant Mucinous Carcinoma Originating from the Appendix: A Case Report. International Surgery 2021; 105(1-3) doi: 10.9738/INTSURG-D-20-00044.1
|
| 273 |
Barbara Link, Adriana Torres Crigna, Michael Hölzel, Frank A. Giordano, Olga Golubnitschaja. Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes?. Journal of Clinical Medicine 2021; 10(21) doi: 10.3390/jcm10215124
|
| 274 |
Patrick Michl, Matthias Löhr, John P. Neoptolemos, Gabriele Capurso, Vinciane Rebours, Nuria Malats, Mathilde Ollivier, Luigi Ricciardiello. UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better. United European Gastroenterology Journal 2021; 9(7) doi: 10.1002/ueg2.12123
|
| 275 |
Abdulaziz Elemosho, Odysseas P. Chatzipanagiotou, Meher Angez, Andrea Baldo, Areesh Mevawalla, Qaidar Alizai, Timothy M. Pawlik. Early postoperative carbohydrate antigen 19-9 normalization drives prognosis after pancreatic ductal adenocarcinoma resection. Journal of Gastrointestinal Surgery 2026; 30(8) doi: 10.1016/j.gassur.2026.102459
|